Ghisallo Capital Management LLC Lian Bio Transaction History

Ghisallo Capital Management LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 10, 2022	SELL	$2.8 - $6.21 $280,000 - $621,000	-100,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.14 - $16.2 $614,000 - $1.62 Million	100,000 New	100,000 $616,000

1.09M

Ticker LIAN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,354,000
Market Cap $32.5M
Description
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...

Get notified when there are updates to the investment portfolio of Ghisallo Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ghisallo Capital Management LLC with notifications on news.